Dawa Limited is one of the leading pharmaceutical manufacturers of human healthcare products in Kenya and East Africa. Through our specialised human health division, we have over the decades provided front-line products that have ensured enhanced quality of life for patients.
In 2004, Medisel (Kenya) Limited acquired Dawa Limited as a strategy to grow and enhance the company’s position in East Africa’s pharmaceutical industry. This also enabled Dawa Limited to leverage on the expansive network of its new parent company to widen Dawa Limited’s market reach. Today, our products can be found in virtually every African country, thanks to our commercial operations in more than 10 countries in Eastern, Central and Western Africa.
We envisage our company growing to become one of the leading global pharmaceutical manufacturers. To meet the market demand for various types of antibiotics in the region, Dawa Limited has been pursuing an aggressive growth strategy, which has seen the company setting up a state-of-the-art penicillin manufacturing facility.
Penicillins are a type of antibiotics that are used in the prevention and treatment of different kinds of bacterial infections. This new facility places Dawa Limited at the top of the list of Kenya’s leading manufacturers of antibiotics for use in human healthcare products.
We have the requisite capacity to achieve our ambitious growth strategy with an advanced laboratory and equipment in the region. We also employ the best pharmacy graduates from local universities and colleges. Our excellent induction programme matches the graduates with experienced professionals to ensure that the graduates grow into highly resourceful individuals. We then place the most promising personnel in strategic positions to propel the company further into market leadership. With this, nothing stands in the way to our success and sustainability as a company.